$AVXL
Anavex Life Sciences Corp.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · New York, NY
AVXL chart
What traders are saying about $AVXL
Latest postsAnavex Life Sciences Corp. news
- What's Next for Anavex Life Sciences Corp. Shareholders After 6.35% Stock Drop? Glancy Prongay Wolke & Rotter LLP Explains Securities Fraud Class Action Lead Plaintiff Deadline
PR Newswire ·
- Discovering Opportunities: Anavex Life Sciences And 2 Other Promising Penny Stocks
Simply Wall Street ·
- Anavex Life Sciences (AVXL) Slips 2.21% to $1.33 as Shares Drift Toward Lower Support - Volume Oscillator
https://www.siam.in/ ·
- Anavex Life Sciences Corp. Estimates – NASDAQ:AVXL
TradingView ·
- What Should Anavex Life Sciences Corp. Investors Know After 6.35% Stock Drop? The Law Offices of Frank R. Cruz Outlines Securities Fraud Class Action Lead Plaintiff Deadline
PR Newswire ·
- AVXL INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Anavex Life Sciences Corp. Investors Have Opportunity to Lead Class Action Lawsuit!
ACCESS Newswire ·
- INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Anavex Life Sciences Corp. of Class Action Lawsuit and Upcoming Deadlines - AVXL
PR Newswire ·
- ROSEN, THE FIRST FILING FIRM, Encourages Anavex Life
GlobeNewswire ·
- Aevex stock drops 5% as US Navy halts $130M drone boat program
Yahoo Finance ·
- Form 8K Anavex Life Sciences Corp For: 20 October By Investing.com
Investing.com Canada ·
- Anavex Life Sciences Announces Completion of ADME and DDI Pharmacology Studies for Blarcamesine
Kalkine Media ·
- Anavex Provides Corporate Update, Announces Completion of Clinical Conduct of ADME and DDI Clinical Studies
Yahoo Finance ·
Anavex Life Sciences Corp. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$46.4M | -$43.0M | -$47.5M | -$48.0M |
| Diluted EPS | $-0.54 | $-0.52 | $-0.60 | $-0.62 |
| Total assets (year end) | $133.0M | $124.0M | $148.1M | $148.4M |
| Cash and equivalents (year end) | $131.7M | $120.8M | $143.8M | $143.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Anavex Life Sciences Corp.
- Ticker
- AVXL (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- New York, NY
- Fiscal year end
- September 30
- SEC CIK
- 1314052
- Former names
- Thrifty Printing Inc.
Frequently asked questions
What exchange is Anavex Life Sciences Corp. listed on?
Anavex Life Sciences Corp. trades on the Nasdaq under the ticker symbol AVXL.
What industry is Anavex Life Sciences Corp. in?
Anavex Life Sciences Corp. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Anavex Life Sciences Corp. headquartered?
Anavex Life Sciences Corp.'s business address on file with the SEC is in New York, NY.
When does Anavex Life Sciences Corp.'s fiscal year end?
Anavex Life Sciences Corp.'s fiscal year ends on September 30.